← Back to Search

Remote CGM Monitoring for Type 1 Diabetes

Q: Does the age limit for participants in this trial extend to those who are retired?

To be eligible for this particular trial, applicants must aged 0 to 21. Out of the 1,195 total trials, 227 are for those under 18 and 968 are for seniors above 65.

Q: Could I potentially qualify to be a part of this research project?

We are looking for 100 individuals with <a href="https://www.withpower.com/clinical-trials/type-1-diabetes">type 1 diabetes</a> mellitus that are below the age of 21. The participants must also agree to follow-up care at the Stanford Children's Diabetes Clinic and CGM data integration into the electronic medical record (EMR) for remote monitoring.

Q: Are we currently recruiting for this research project?

No, this particular study is not actively recruiting patients according to the latest information available on clinicaltrials.gov. This site was last updated on 3/15/2021 and shows that the trial was initially posted on 3/25/2019. Although this specific trial is not looking for candidates right now, there are 1,312 other trials that are currently open to participants.

N/A

Waitlist Available

Led By Priya Prahalad, MD, PhD

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age: birth to < 21 years of age

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial will test whether increased contact between patients and their care team can improve diabetes outcomes. Continuous glucose monitor data will be used to proactively reach out to patients and their families for more frequent dose adjustments.

Who is the study for?

This trial is for children and young adults up to 21 years old who have been newly diagnosed with Type 1 Diabetes within the last month. Participants must be seen at Stanford Children's Diabetes Clinic, agree to share their continuous glucose monitor (CGM) data for remote monitoring, and plan to continue their follow-up care at the same clinic.Check my eligibility

What is being tested?

The study aims to see if more contact between patients and healthcare providers through a system called GluVue can help manage diabetes better in the first year after diagnosis. This involves integrating CGM data into the patient's electronic medical record for closer monitoring.See study design

What are the potential side effects?

Since this trial focuses on remote monitoring of existing CGM devices rather than testing new medications or treatments, there are no direct side effects from interventions being studied.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am younger than 21 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Contacts with the care provider

Secondary outcome measures

Hemoglobin A1c

Trial Design

1Treatment groups

Experimental Treatment

Group I: Patients with Type 1 DiabetesExperimental Treatment1 Intervention

Participants will wear a continuous glucose monitor (CGM) and receive remote monitoring of the CGM data by the clinical care team.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor

2,386 Previous Clinical Trials

17,333,908 Total Patients Enrolled

Priya Prahalad, MD, PhDPrincipal InvestigatorStanford University

Media Library

Remote Monitoring of CGM Data Clinical Trial Eligibility Overview. Trial Name: NCT03968055 — N/A

Type 1 Diabetes Research Study Groups: Patients with Type 1 Diabetes

Type 1 Diabetes Clinical Trial 2023: Remote Monitoring of CGM Data Highlights & Side Effects. Trial Name: NCT03968055 — N/A

Remote Monitoring of CGM Data 2023 Treatment Timeline for Medical Study. Trial Name: NCT03968055 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the age limit for participants in this trial extend to those who are retired?

"To be eligible for this particular trial, applicants must aged 0 to 21. Out of the 1,195 total trials, 227 are for those under 18 and 968 are for seniors above 65."

Answered by AI

Could I potentially qualify to be a part of this research project?

"We are looking for 100 individuals with type 1 diabetes mellitus that are below the age of 21. The participants must also agree to follow-up care at the Stanford Children's Diabetes Clinic and CGM data integration into the electronic medical record (EMR) for remote monitoring."

Answered by AI

Are we currently recruiting for this research project?

"No, this particular study is not actively recruiting patients according to the latest information available on clinicaltrials.gov. This site was last updated on 3/15/2021 and shows that the trial was initially posted on 3/25/2019. Although this specific trial is not looking for candidates right now, there are 1,312 other trials that are currently open to participants."

Answered by AI

Recent research and studies

The Journal of Clinical Endocrinology & MetabolismJournal

Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: The Pilot 4T Study

Prahalad, Priya, Victoria Y Ding, Dessi P Zaharieva, Ananta Addala, Ramesh Johari, David Scheinker, Manisha Desai, Korey Hood, and David M Maahs. 2021. “Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Type 1 Diabetes: The Pilot 4T Study”. The Journal of Clinical Endocrinology & Metabolism. The Endocrine Society. doi:10.1210/clinem/dgab859.

clinicaltrials.govStudy

Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)

Priya Prahalad 2019. "Remote Monitoring of CGM Data in Pediatric Patients With Newly Diagnosed Type 1 Diabetes (T1D)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03968055.

All > Type 1 Diabetes